I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Three Bispecific Antibody Programs Sep 26, 2018 Life Science
$80 Million Series B Financing Funds Morphic Therapeutic’s Next-Generation Oral Integrin Sep 25, 2018 Life Science
Quest Diagnostics to Acquire U.S. Laboratory Services Business of Oxford Immunotec Sep 25, 2018 Life Science
VenatoRx Pharmaceuticals and Everest Medicines II Limited Announce Exclusive License Agreement for cefepime/VNRX-5133 Sep 25, 2018 Life Science
Aurora Cannabis revenues more than triples to $19.1 million in fourth quarter Sep 24, 2018 Cannabis, Life Science
British Biologicals’ USA Leadership Team Equipped for Launch of NEW California Based Operating Facility Sep 24, 2018 Life Science
Kalorama Information Reports IVD Markets in China, South Korea and Vietnam Reach $3.7 Billion Sep 24, 2018 Life Science
Bay Area’s uBiome Secures $83 Million as It Moves into Drug Development, Taps ex-Novartis CEO for Its Board Sep 21, 2018 Life Science
Acadia Pharma Soars After FDA Investigation Clears Nuplazid of Additional Safety Problems Sep 21, 2018 Life Science
MeMed Raises Over $70 Million to Advance Pioneering Point-Of-Care Platform and Immune-Based Test for Distinguishing Bacterial Versus Viral Infections Sep 21, 2018 Life Science
Changchun High & New Forms $200 Million Biosimilar JV with Alvotech of Iceland Sep 21, 2018 Life Science
Cannmart receives Health Canada’s first ACMPR sales-only license and announces special edition Namaste Live 420 Sunday Sept 23rd at 7PM EST Sep 21, 2018 Life Science
The Canadian cannabis producer that was in talks with Coca-Cola to make a CBD-infused drink is reportedly targeting a US IPO in October Sep 20, 2018 Cannabis, Life Science
